| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 10 | 0 | 0 | 10 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| AR protein | 15 | 0 | 0 | 15 |
| aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 10 | 0 | 0 | 10 |
| retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
| estrogen nuclear receptor alpha | 18 | 0 | 0 | 18 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| Histone H2A.x | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| Voltage-dependent calcium channel gamma-2 subunit | 7 | 0 | 0 | 7 |
| Glutamate receptor 2 | 7 | 0 | 0 | 7 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 7 | 0 | 0 | 7 |
| GLS protein | 5 | 0 | 0 | 5 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 8 | 1 | 2 | 11 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| ATAD5 protein, partial | 7 | 0 | 0 | 7 |
| Microtubule-associated protein tau | 3 | 0 | 0 | 3 |
| Smad3 | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| progesterone receptor | 9 | 0 | 0 | 9 |
| EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
| estrogen-related nuclear receptor alpha | 13 | 0 | 0 | 13 |
| peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
| aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
| chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform 2 | 9 | 0 | 0 | 9 |
| peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 3 | 1 | 0 | 4 |
| ATP-binding cassette sub-family C member 3 | 0 | 9 | 0 | 9 |
| Multidrug resistance-associated protein 4 | 0 | 9 | 0 | 9 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Bile salt export pump | 0 | 16 | 0 | 16 |
| Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 6 | 0 | 7 |
| Carbonic anhydrase 2 | 0 | 6 | 1 | 8 |
| Myoglobin | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
| Cytochrome P450 1A2 | 0 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 1 | 0 | 4 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 1 | 0 | 4 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 1 | 0 | 4 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 1 | 0 | 4 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 3 | 1 | 1 | 5 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 2 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 1 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 1 | 0 | 4 |
| Carbonic anhydrase 9 | 0 | 3 | 0 | 3 |
| GABA theta subunit | 3 | 1 | 0 | 4 |
| Canalicular multispecific organic anion transporter 1 | 0 | 9 | 0 | 9 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit epsilon | 3 | 1 | 0 | 4 |
| Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 3 |
| toxin B | 0 | 0 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 2 | 0 | 0 | 2 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
| NPYLR7B | 0 | 0 | 2 | 2 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| IDH1 | 6 | 0 | 0 | 6 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| mitogen-activated protein kinase 1 | 4 | 0 | 0 | 4 |
| flap endonuclease 1 | 6 | 0 | 0 | 6 |
| nuclear receptor ROR-gamma isoform 1 | 4 | 0 | 0 | 4 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 3 | 0 | 3 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 6 | 2 | 9 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 1 | 1 | 2 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 1 | 3 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 2 | 4 |
| Adenosine receptor A2b | 0 | 0 | 1 | 2 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 2 | 5 |
| Adenosine receptor A2a | 0 | 2 | 1 | 3 |
| Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
| Adenosine receptor A1 | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
| Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| PPM1D protein | 6 | 0 | 0 | 6 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| TDP1 protein | 12 | 0 | 0 | 12 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
| farnesoid X nuclear receptor | 4 | 0 | 0 | 4 |
| pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
| G | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| polyprotein | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| euchromatic histone-lysine N-methyltransferase 2 | 13 | 0 | 0 | 13 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 5 | 0 | 0 | 5 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| geminin | 11 | 0 | 0 | 11 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
| Interferon beta | 7 | 0 | 0 | 7 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Cellular tumor antigen p53 | 9 | 0 | 0 | 9 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 5 | 1 | 9 |
| Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 8 |
| ATP-dependent translocase ABCB1 | 0 | 6 | 1 | 9 |
| Integrin alpha-IIb | 3 | 1 | 0 | 4 |
| Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 8 |
| Alpha-2A adrenergic receptor | 0 | 8 | 0 | 8 |
| Cytochrome P450 2C8 | 0 | 3 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 9 |
| Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
| D(2) dopamine receptor | 0 | 4 | 0 | 4 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Alpha-1B adrenergic receptor | 0 | 7 | 0 | 7 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 5 | 1 | 8 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 3 | 0 | 3 |
| D(4) dopamine receptor | 0 | 4 | 0 | 4 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Endothelin-1 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
| Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 4 | 1 | 5 |
| D(3) dopamine receptor | 0 | 4 | 0 | 4 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
| C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 7 | 0 | 7 |
| Histamine H2 receptor | 2 | 0 | 1 | 4 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Ataxin-2 | 6 | 0 | 0 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 7 | 1 | 8 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
| Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 8 | 0 | 0 | 8 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| cystic fibrosis transmembrane conductance regulator | 0 | 2 | 0 | 2 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 1 | 2 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Riboflavin-binding protein | 0 | 0 | 1 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 2 |
| Procathepsin L | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1a | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
| Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
| Spike glycoprotein | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
| DNA ligase 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| DNA ligase A | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 2 | 3 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| Cytochrome P450 2B6 | 0 | 3 | 0 | 3 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| PAX8 | 0 | 0 | 0 | 2 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 3 | 0 | 0 | 3 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| NS5 | 0 | 0 | 1 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| Glucose transporter | 0 | 1 | 0 | 1 |
| Serine hydrolase RBBP9 | 0 | 1 | 0 | 1 |
| Hexose transporter 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 2 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 2 |
| Luciferase | 4 | 0 | 0 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Sphingosine 1-phosphate receptor 1 | 0 | 0 | 1 | 1 |
| RCG53912, isoform CRA_a | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| citrate synthase 2, partial | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| LAP4 | 0 | 0 | 1 | 1 |
| MEP2 | 0 | 0 | 1 | 1 |
| vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 2 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 2 | 5 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 3 | 0 | 3 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 1 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| Glucocorticoid receptor | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| GALC protein | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Protein argonaute-2 | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 2 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |